LENZ Therapeutics (LENZ) Accumulated Depreciation (2020 - 2023)

LENZ Therapeutics (LENZ) has 4 years of Accumulated Depreciation data on file, last reported at $838000.0 in Q3 2023.

• Accumulated Depreciation for Q3 2023 came in at $838000.0, down 66.81% year-over-year; the trailing twelve-month figure through Sep 2023 was $838000.0 (down 66.81% YoY), and the FY2022 annual result was $3.2 million, up 275.09% from the prior year.
• Accumulated Depreciation slipped to $838000.0 in Q3 2023 per LENZ's latest filing, from $3.3 million in the prior quarter.
• Over five years, Accumulated Depreciation peaked at $3.9 million in Q1 2023 and troughed at $121000.0 in Q4 2020.
• A 4-year average of $1.7 million and a median of $1.3 million in 2022 frame the typical range for Accumulated Depreciation.
• The sharpest annual moves came in 2021 and 2023: Accumulated Depreciation jumped 606.61% in 2021, then plunged 66.81% in 2023.
• A 4-year view of Accumulated Depreciation shows it stood at $121000.0 in 2020, then jumped by 606.61% to $855000.0 in 2021, then jumped by 275.09% to $3.2 million in 2022, then tumbled by 73.87% to $838000.0 in 2023.
• Business Quant data shows LENZ's Accumulated Depreciation at $838000.0 in Q3 2023, $3.3 million in Q2 2023, and $3.9 million in Q1 2023.